HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP Supplement Manufacturing Practices Chapter Helps Fill FDA GMP Gap

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Pharmacopeia's revised general chapter entitled "Manufacturing Practices for Dietary Supplements" gives industry another resource it can use while waiting for FDA to issue its proposed rule on dietary supplement Good Manufacturing Practices

You may also be interested in...



NNFA, NSF Unite Supplement Testing Efforts; USP Program Clears Board

The dietary supplement certification alliance formed by NSF International and NNFA will yield cost efficiencies for firms participating in both programs and could make testing more affordable to smaller manufacturers, the groups said

Nature's Way, Wakunaga Receive First NNFA GMP Certifications

All Nature's Way dietary supplements will carry the NNFA good manufacturing practices logo on their protective seal or shrink-wrap by mid-September. The seal may be incorporated directly onto the company's packaging when future labeling changes or line extensions are introduced, according to the firm.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS130688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel